Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Armata Pharmaceuticals, Inc. (ARMP) EPS (Weighted Average and Diluted) (2016 - 2018)

Armata Pharmaceuticals' EPS (Weighted Average and Diluted) history spans 6 years, with the latest figure at -$3.08 for Q4 2018.

  • For Q4 2018, EPS (Weighted Average and Diluted) fell 769.02% year-over-year to -$3.08; the TTM value through Dec 2018 reached -$4.36, up 62.67%, while the annual FY2024 figure was -$0.89, 53.4% up from the prior year.
  • EPS (Weighted Average and Diluted) for Q4 2018 was -$3.08 at Armata Pharmaceuticals, down from -$0.6 in the prior quarter.
  • Across five years, EPS (Weighted Average and Diluted) topped out at $3.3 in Q3 2014 and bottomed at -$10.13 in Q4 2016.
  • The 5-year median for EPS (Weighted Average and Diluted) is -$0.68 (2018), against an average of -$1.71.
  • The largest annual shift saw EPS (Weighted Average and Diluted) soared 1592.86% in 2014 before it tumbled 976.67% in 2016.
  • A 5-year view of EPS (Weighted Average and Diluted) shows it stood at -$0.44 in 2014, then soared by 31.82% to -$0.3 in 2015, then tumbled by 3276.67% to -$10.13 in 2016, then skyrocketed by 96.5% to -$0.35 in 2017, then tumbled by 769.02% to -$3.08 in 2018.
  • Per Business Quant, the three most recent readings for ARMP's EPS (Weighted Average and Diluted) are -$3.08 (Q4 2018), -$0.6 (Q3 2018), and -$0.68 (Q2 2018).